These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34578349)

  • 21. Recent advances in the molecular and cellular biology of bunyaviruses.
    Walter CT; Barr JN
    J Gen Virol; 2011 Nov; 92(Pt 11):2467-2484. PubMed ID: 21865443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984.
    Rodhain F; Gonzalez JP; Mercier E; Helynck B; Larouze B; Hannoun C
    Trans R Soc Trop Med Hyg; 1989; 83(6):851-4. PubMed ID: 2559514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.
    Lerolle S; Freitas N; Cosset FL; Legros V
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity.
    Schlotthauer F; McGregor J; Drummer HE
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33946211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Host-adaptive antigenic variation in Bunyaviruses.
    James WS; Millican D
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2803-6. PubMed ID: 2432166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccination regimes against Schmallenberg virus infection in IFNAR
    Boshra HY; Charro D; Lorenzo G; Sánchez I; Lazaro B; Brun A; Abrescia NG
    Antiviral Res; 2017 May; 141():107-115. PubMed ID: 28235558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies.
    Pifat DY; Osterling MC; Smith JF
    Virology; 1988 Dec; 167(2):442-50. PubMed ID: 2462308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bunyavirus-vector interactions.
    Horne KM; Vanlandingham DL
    Viruses; 2014 Nov; 6(11):4373-97. PubMed ID: 25402172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bunyavirus: structure and replication.
    Guu TS; Zheng W; Tao YJ
    Adv Exp Med Biol; 2012; 726():245-66. PubMed ID: 22297517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel method for performing antigenic vaccine matching for foot-and-mouth disease in absence of the homologous virus.
    Sirdar MM; Fosgate GT; Blignaut B; Gummow B; Shileyi B; Lazarus DD; Mutowembwa P; van der Merwe D; Heath L
    Vaccine; 2019 Aug; 37(35):5025-5034. PubMed ID: 31296377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Viral Surface Proteins through Structure-Based Design.
    Narkhede YB; Gonzalez KJ; Strauch EM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N-terminal domain of Schmallenberg virus envelope protein Gc is highly immunogenic and can provide protection from infection.
    Wernike K; Aebischer A; Roman-Sosa G; Beer M
    Sci Rep; 2017 Feb; 7():42500. PubMed ID: 28211908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a recombinant Akabane mutant virus with knockout of a nonstructural protein NSs in a pregnant goat model.
    Takenaka-Uema A; Bangphoomi N; Shioda C; Uchida K; Gen F; Kato K; Haga T; Murakami S; Akashi H; Hoimoto T
    Virol Sin; 2016 Jun; 31(3):274-7. PubMed ID: 27068656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
    Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
    Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic relationships among Turlock serogroup Bunyaviruses as determined by neutralization tests.
    Calisher CH; Lazuick JS; Wolff KL; Muth DJ
    Acta Virol; 1984 Mar; 28(2):148-51. PubMed ID: 6203387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bunyaviridae RdRps: structure, motifs, and RNA synthesis machinery.
    Amroun A; Priet S; de Lamballerie X; Quérat G
    Crit Rev Microbiol; 2017 Nov; 43(6):753-778. PubMed ID: 28418734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimeric single-domain antibody complexes protect against bunyavirus infections.
    Wichgers Schreur PJ; van de Water S; Harmsen M; Bermúdez-Méndez E; Drabek D; Grosveld F; Wernike K; Beer M; Aebischer A; Daramola O; Rodriguez Conde S; Brennan K; Kozub D; Søndergaard Kristiansen M; Mistry KK; Deng Z; Hellert J; Guardado-Calvo P; Rey FA; van Keulen L; Kortekaas J
    Elife; 2020 Apr; 9():. PubMed ID: 32314955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccine design using reverse and structural vaccinology, ontology-based literature mining and machine learning.
    Huffman A; Ong E; Hur J; D'Mello A; Tettelin H; He Y
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in veterinary applications of structural vaccinology.
    Charleston B; Graham SP
    Curr Opin Virol; 2018 Apr; 29():33-38. PubMed ID: 29550741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.